发明名称 SINGLE-DOSE ADMINISTRATION OF FACTOR VIIa
摘要 The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of a Factor VIIa equivalent. Preferably, the single dose comprises between about 150 and about 500 ug/kg Factor VIIa equivalent.
申请公布号 US2017106060(A1) 申请公布日期 2017.04.20
申请号 US201615249598 申请日期 2016.08.29
申请人 Novo Nordisk HealthCare AG 发明人 Hedner Ulla
分类号 A61K38/48;A61K45/06;A61K9/00 主分类号 A61K38/48
代理机构 代理人
主权项 1. A method for treating a bleeding episode in a subject in need of such treatment, said method comprising administering intravenously to said subject a Factor VIIa equivalent, wherein said administering is in a single dose and said dose comprises a single-dose-effective amount of said Factor VIIa equivalent and wherein, subsequent to said administration, no further Factor VIIa equivalent is administered to said subject for a period of at least 4 hours.
地址 Zurich CH